This site is intended for healthcare professionals

Long-term IL-23 inhibitor safety and efficacy data in vulnerable psoriasis patient groups

Bookmark
Is there any data regarding the long-term safety and efficacy IL-23 inhibitors in vulnerable patient populations and why is this an important consideration?